Emcure Pharmaceuticals To Launch Oral Covid-19 Drug In India
[email protected]13 Jan, 2022News
New Delhi, Dec 31 (IANS) Homegrown Emcure Pharmaceuticals Ltd on Friday announced that it has received Emergency Use Authorisation (EUA) approval for the launch of Molnupiravir, an investigational oral anti-viral drug, for the treatment of mild Covid-19. The pharmaceutical company, which has received approval from the Drug Controller General of India, said that it plans to launch Molnupiravir under the brand name Lizuvira in the Indian market.
Related Bookmarks
- Emcure Pharma To Unveil Oral Covid-19 Drug In A Week
- Emcure Pharmaceuticals To Launch Lizuvira
- Namita Thapar Biography, Net Worth, Early Life, Career, Family
- Cultivators� Notes For Dolato Cannabis Strain
- 3 Expected Pharmaceutical IPOs In 2022
- Onsite Position in dallas & Good Employee Benefits in dallas & Immigration Sponsor in dallas
- Sell Old Vinyl Records Online
- What is the Worth of a Moving Company in St. Catharines?
- H1B Sponsor in dallas & KBK IT Services
- GC Sponsor in dallas & KBK IT Services H1B Sponsor in dallas
Recent Profiles
Phtaya Premier Online Hub For Slots Live Casino
Chapman Cooke
Manning Gould
Guldager Hodges
88bet
I9bet
Townsend Martinsen
Bond Hove
Holder Elgaard
Gacor 368